Skip to content

Senior Research Associate, Assay Development - PM Shift (Contract)

DelfidiagnosticsPalo Alto, CA

First seen Oct 23 · open 28 days · posted onceNo pay listed

HirQ verdict

62/100 · Fair. Based on age, reposts, pay, the company's hiring and ghost signals.

Low ghost risk
True age
28 days
Reposts
Posted once

See the evidence behind this score.

Pro shows each part of the score, the reasons, the pay percentile and the listing history.

HirQ's ghost-risk estimate and company labels are automated opinions based on what we observe on employers' public job boards: how long a listing has been open, whether it was re-listed, wording in the description, and how often roles on that board close. They are not statements about an employer's intent, and a high-risk listing can still be a real opening. Figures are as of the date shown. How we measure

At a glance

Pay
No pay listed
Level
Senior
Type
Contract
Team
Research & Development
Work setup
On-site

“Palo Alto, CA”

Pay vs market

Employer-posted ranges for Science & Research roles in CA in the last 12 months (744 postings).

$133k
25th pct/yr
$177k
Median/yr
$250k
75th pct/yr
$90k · 10th90th · $330k

This job: No pay listed

Delfidiagnostics hiring

Company page
Actively hiringHiring57· FairBiotech & Pharma
Open roles
7
New in 30 days
5
Closed in 30 days
4
Hiring trend, 13 weeksPro
Follow-through: ••%Pro

About the role

From Delfidiagnostics's careers page, checked Nov 21

DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
Lead with Science, Anchor in Pragmatism: We pioneer life-changing science by ensuring quality, transparency, and rigor at all times. We explore thoughtfully, experiment smartly, and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class
Put We over I: We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us--win. We show up with empathy, humility, and integrity at every step of the journey.

Apply on Delfidiagnostics's siteOpens Delfidiagnostics's own application page.

Similar jobs

Same role or field, nearby or remote, ranked by HirQ score.

More at Delfidiagnostics

All roles

Keep exploring

Senior Research Associate, Assay Development - PM Shift (Contract)

No pay listed · HirQ 62

Apply